ArticleCadernos de saude publica2025
[Diabetes mellitus: complications associated with time since diagnosis, health insurance, use of health services, and medication use, Brazilian National Health Survey 2019].
Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Type 2 diabetes morbidity, mortality and its associated risk factors across Brazilian regions: findings from the Global Burden of Disease Study 2021.Archives of endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to estimate the occurrence of diabetes mellitus complications in adults and their association with the time since diagnosis, health insurance coverage, use of health services, and medication use. This is a population-based cross-sectional study using data from the 2019 Brazilian National Health Survey (PNS). Individuals aged ≥ 40 years (n = 54,987) were considered, and the prevalence of diabetes and its complications, as well as medication use, was estimated. Associations between the occurrence of the selected complications and the time since diabetes diagnosis, health insurance coverage, and health service use were examined using both crude and adjusted prevalence ratios, employing Poisson regression with robust variance. The prevalence of diabetes in the study population was 13.4% (95%CI: 12.9-13.9), and that of complications was 31% (95%CI: 29.2-32.9). The most prevalent complications were vision problems (29.6%; 95%CI: 27.6-31.6) and kidney problems (9.2%; 95%CI: 8.2-10.4). The prevalence of all complications increased with the time since diagnosis (p < 0.05). The prevalence of vision problems was higher among individuals without health insurance (32.7% vs. 21.5%; p < 0.001) and among those who had seen a doctor in the last six months (31.1% vs. 25.2%; p = 0.007) compared to those whose last visit was between six months and less than three years. Medication use among those with complications was 93.3% (95%CI: 91.5-94.8); however, more than 1.5 million people in this group were not using their prescribed medications. Strengthening actions by the Brazilian Unified National Health System (SUS) are necessary, particularly screening exams for the early identification of diabetes mellitus and its complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.